1. Home
  2. BSRR vs ARVN Comparison

BSRR vs ARVN Comparison

Compare BSRR & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sierra Bancorp

BSRR

Sierra Bancorp

HOLD

Current Price

$40.39

Market Cap

532.1M

Sector

Finance

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.06

Market Cap

516.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSRR
ARVN
Founded
1977
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
532.1M
516.2M
IPO Year
2001
2018

Fundamental Metrics

Financial Performance
Metric
BSRR
ARVN
Price
$40.39
$8.06
Analyst Decision
Buy
Buy
Analyst Count
3
19
Target Price
$37.00
$15.05
AVG Volume (30 Days)
58.2K
535.5K
Earning Date
04-27-2026
05-04-2026
Dividend Yield
2.93%
N/A
EPS Growth
10.28
58.84
EPS
1.72
N/A
Revenue
N/A
$262,600,000.00
Revenue This Year
$11.74
N/A
Revenue Next Year
$3.63
N/A
P/E Ratio
$23.70
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.49
$6.06
52 Week High
$43.13
$14.22

Technical Indicators

Market Signals
Indicator
BSRR
ARVN
Relative Strength Index (RSI) 47.39 42.81
Support Level $39.72 $7.90
Resistance Level $42.17 $8.40
Average True Range (ATR) 1.44 0.26
MACD -0.21 -0.01
Stochastic Oscillator 47.82 13.86

Price Performance

Historical Comparison
BSRR
ARVN

About BSRR Sierra Bancorp

Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. It offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: